The FDA is about to decide which peptides could soon become widely available in the U.S. Here’s what happens next.

The FDA is evaluating whether seven peptides, including BPC-157 and TB-500, can be legally compounded, which may lead to increased availability in the U.S. The decision could determine the legal status of these peptides for broader use among Americans.